News & Articles

Easy-to-use molecular biology test delivers results in less than one hour

The study is the first global, randomized, double-blind, placebo-controlled phase III trial investigating Actemra/RoActemra in this setting

The analyzer with LowDoseID for narcotics analysis eliminates concentration limitations from testing process

Exclusive interviews, new methods, free downloads and much more to help advance your biopharmaceutical research

Watch this webinar to find out how metabolomics research is utilizing mass spectrometry advancements

Find out how collaboration between Pall and key life sciences researchers is helping to innovate and accelerate biologic development

Saphyr’s extremely sensitive structural variation detection technology will be used to analyze samples from COVID patients from dozens of clinical sites throughout North America and Europe

Download this free eBook today to streamline development and accelerate time-to-market

Find out how LC-MS technology is being used to quantify the experimental drug remdesivir

The ViroKey™ SARS-CoV-2 RT-PCR Test v2.0 is a probe-based reverse transcription PCR test

The NeuroSphere Digital Care offers flexible virtual care options as the COVID-19 global pandemic impacts how healthcare is administered

Thermo Fisher Scientific’s ImmunoCAP Specific IgE alpha-Gal Allergen Component test helps clinicians pinpoint a potentially fatal allergy often resulting from tick bites

This on-demand webinar shows how cutting-edge liquid handling, automation, and detection technologies can increase speed and efficiency in your lab

Partnership to co-commercialize pralsetinib, an investigational, precision therapy in late-stage development

AccuPlex™ SARS-CoV-2 Verification Panel and Reference Material Kit are now available with full SARS-CoV-2 viral genome coverage

Based on the results, the U.S.-based trial has been stopped, including in a second cohort of patients who received a higher dose of Kevzara (800 mg)

Partnerships, products, and solutions facilitate detection, research, and vaccine development to combat the SARS-CoV-2 virus

The “triple antibody” test will provide health professionals with an accurate indication of the presence of IgA, IgM and IgG COVID-19 antibodies within 10 minutes

Establishing a broad range of remotely accessible COVID-19 assays including biochemical profiling for COVID-19 drug targets

A new test being developed by Iceni Diagnostics promises a quick way to distinguish between the two diseases

Promega automated sample preparation solution added to CDC COVID-19 test protocol

The test is intended to expand availability of COVID-19 screening resources in central Ohio

Interim data shows strong antibody and T-cell responses in all evaluated participants